Management of hypertension before, during, and after pregnancy
暂无分享,去创建一个
[1] F. Luft,et al. When should pregnant women with an elevated blood pressure be treated? , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] G. Prescott,et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study , 2003, BMJ : British Medical Journal.
[3] T. Easterling,et al. Treatment of Hypertension in Pregnancy: Effect of Atenolol on Maternal Disease, Preterm Delivery, and Fetal Growth , 2001, Obstetrics and gynecology.
[4] J. Troendle,et al. Risks of hypertensive disorders in the second pregnancy. , 2001, Paediatric and perinatal epidemiology.
[5] J. Pell,et al. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births , 2001, The Lancet.
[6] J. Kooner,et al. Association of maternal endothelial dysfunction with preeclampsia. , 2001, JAMA.
[7] F. Pipkin. Risk factors for preeclampsia. , 2001, The New England journal of medicine.
[8] A. Hagiwara,et al. Losartan and fetal toxic effects , 2001, The Lancet.
[9] G. H. Lambert,et al. Transfer of drugs and other chemicals into human milk. , 2001, Pediatrics.
[10] L. Irgens,et al. Predicting Preeclampsia in the Second Pregnancy from Low Birth Weight in the First Pregnancy , 2000, Obstetrics and gynecology.
[11] James J. Walker,et al. Pre-eclampsia , 2000, The Lancet.
[12] J. Higgins,et al. The detection, investigation and management of hypertension in pregnancy: full consensus statement , 2000, The Australian & New Zealand journal of obstetrics & gynaecology.
[13] G Koren,et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis , 2000, The Lancet.
[14] R. North,et al. Mid‐trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high‐risk women , 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[15] G. Hofmeyr,et al. Bed rest in hospital for suspected impaired fetal growth. , 1996, The Cochrane database of systematic reviews.
[16] M. Faas,et al. Etiology and pathogenesis of preeclampsia: current concepts. , 1999, American journal of obstetrics and gynecology.
[17] L. Poston,et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial , 1999, The Lancet.
[18] C. Hubel,et al. Is oxidative stress the link in the two-stage model of pre-eclampsia? , 1999, The Lancet.
[19] R. Mann,et al. Losartan: a study of pharmacovigilance data on 14 522 patients , 1999, Journal of Human Hypertension.
[20] E. Seely. Hypertension in pregnancy: a potential window into long-term cardiovascular risk in women. , 1999, The Journal of clinical endocrinology and metabolism.
[21] L. Magee,et al. Fortnightly review: management of hypertension in pregnancy. , 1999, BMJ.
[22] R. Matijević,et al. In vivo assessment of failed trophoblastic invasion of the spiral arteries in pre‐eclampsia , 1999, British journal of obstetrics and gynaecology.
[23] A. Dumont,et al. [Risk factors in pre-eclampsia]. , 1999, Presse medicale.
[24] M. Brown,et al. Does gestational hypertension become pre‐eclampsia? , 1998, British journal of obstetrics and gynaecology.
[25] R. Burrows,et al. Assessing the Teratogenic Potential of Angiotensin‐Converting Enzyme Inhibitors in Pregnancy , 1998, The Australian & New Zealand journal of obstetrics & gynaecology.
[26] B. Sibai,et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. , 1998, The New England journal of medicine.
[27] S. Walsh. Maternal-Placental Interactions of Oxidative Stress and Antioxidants in Preeclampsia , 1998, Seminars in reproductive endocrinology.
[28] J. Roberts,et al. Endothelial Dysfunction in Preeclampsia , 1998, Seminars in reproductive endocrinology.
[29] R. Kaaja. Insulin Resistance Syndrome in Preeclampsia , 1998, Seminars in reproductive endocrinology.
[30] E. Burgess,et al. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[31] J. Penny,et al. Blood pressure measurement in severe pre-eclampsia , 1997, The Lancet.
[32] A. Shennan,et al. Accuracy of oscillometric blood pressure monitoring in pregnancy and pre‐eclampsia , 1997, British journal of obstetrics and gynaecology.
[33] S. Ferry,et al. Cardiovascular sequelae of toxaemia of pregnancy. , 1997, Heart.
[34] E. Ferrannini,et al. Hyperinsulinemia in glucose-tolerant women with preeclampsia. A controlled study. , 1996, American journal of hypertension.
[35] C. Hubel. Fasting serum triglycerides, free fatty acids and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours postpartum. , 1996 .
[36] D. Grobbee,et al. Serum lipids in early pregnancy and risk of pre‐eclampsia , 1996, British journal of obstetrics and gynaecology.
[37] R. North,et al. Perinatal morbidity in chronic hypertension , 1996, British journal of obstetrics and gynaecology.
[38] A. Halligan,et al. Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry , 1996, The Lancet.
[39] R. Arngrímsson,et al. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. , 1996, Acta obstetricia et gynecologica Scandinavica.
[40] R. Arngrímsson,et al. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy , 1995 .
[41] P. R. Hein,et al. Dietary sodium restriction in the prophylaxis of hypertensive disorders of pregnancy: effects on the intake of other nutrients. , 1995, The American journal of clinical nutrition.
[42] M. Barr,et al. Teratogen update: angiotensin-converting enzyme inhibitors. , 1994, Teratology.
[43] J. Whitworth,et al. Measuring blood pressure in pregnant women: a comparison of direct and indirect methods. , 1994, American journal of obstetrics and gynecology.
[44] R. Pijnenborg,et al. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre‐eclamptic pregnancies , 1994, British journal of obstetrics and gynaecology.
[45] B. Sibai,et al. Prevention of preeclampsia with low‐dose aspirin in healthy, nulliparous pregnant women , 1993, The New England journal of medicine.
[46] L. Impey. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks , 1993, British journal of obstetrics and gynaecology.
[47] B. Sibai,et al. Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis. , 1992, American journal of obstetrics and gynecology.
[48] C. Redman,et al. Prognosis for pre-eclampsia complicated by 5 g or more of proteinuria in 24 hours. , 1992, European journal of obstetrics, gynecology, and reproductive biology.
[49] D. Wlody,et al. Hypertension in pregnancy. , 1992, The New England journal of medicine.
[50] B. Sibai. Diagnosis and management of chronic hypertension in pregnancy. , 1991, Obstetrics and gynecology.
[51] J. Hargood,et al. Pregnancy‐induced hypertension: recurrence rate in second pregnancies , 1991, The Medical journal of Australia.
[52] Marvin Moser,et al. Working Group Report on High Blood Pressure in Pregnancy , 2001, American journal of obstetrics and gynecology.
[53] W. Lubbe. Treatment of Hypertension in Pregnancy , 1991, Journal of cardiovascular pharmacology.
[54] S. F. Olsen,et al. Fish‐oil and pre‐eclampsia , 1990, British journal of obstetrics and gynaecology.
[55] B. Sibai,et al. A protocol for managing severe preeclampsia in the second trimester. , 1990, American journal of obstetrics and gynecology.
[56] J. Wilson. Transfer of drugs and other chemicals into human milk. , 1989, Pediatrics.
[57] M. Brown,et al. Capillary permeability and extracellular fluid volumes in pregnancy-induced hypertension. , 1989, Clinical science.
[58] M. Charlson,et al. The Prediction of Adverse Outcomes in Antepartum Hypertension , 1989 .
[59] L. M. Mayorga,et al. Magnesium Plus Nifedipine: Potentiation of Hypotensive Effect in Preeclampsia? , 1988, American journal of obstetrics and gynecology.
[60] M. Thompson,et al. Blood pressure in the puerperium. , 1986, Clinical science.
[61] J. Bonnar,et al. The placental bed biopsy: review from three European centers. , 1986, American journal of obstetrics and gynecology.
[62] Sumner J. Yaffe,et al. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 8th Edition , 1986 .
[63] B. Sibai,et al. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. , 1984, American journal of obstetrics and gynecology.
[64] J. Reid,et al. Clinical pharmacological studies with prazosin during pregnancy complicated by hypertension. , 1983, British journal of clinical pharmacology.
[65] T. N. Abdella,et al. Pregnancy Outcome in 211 Patients With Mild Chronic Hypertension , 1983, Obstetrics and Gynecology.
[66] M. J. Teague,et al. NEW DOPPLER TECHNIQUE FOR ASSESSING UTEROPLACENTAL BLOOD FLOW , 1983, The Lancet.
[67] C. Redman,et al. FINAL REPORT OF STUDY ON HYPERTENSION DURING PREGNANCY: THE EFFECTS OF SPECIFIC TREATMENT ON THE GROWTH AND DEVELOPMENT OF THE CHILDREN , 1982, The Lancet.
[68] W. Lubbe. The management of hypertension in pregnancy. , 1981, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[69] S. Hunyor,et al. Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. , 1979, The Quarterly journal of medicine.